Is FDA approval for safety ... or price gouging?
Tuesday, January 19, 2010 - 16:42
in Health & Medicine
Colchicine is the latest drug targeted by an FDA plan to take unapproved drugs through its approval process. But does replacing a cheap, unapproved product with a similar, branded one help the public? Doris Webb was diagnosed last year with a rare disease called familial Mediterranean fever. It's a hereditary condition tied to her French ancestry, causing recurrent fevers, arthritis attacks and inflammation...